Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 241

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The Role of Inflammation in the Pathogenesis of Non-small Cell Lung Cancer

O'Callaghan, Dermot S., O'Donnell, Dearbhaile, O'Connell, Finbarr, O'Byrne, Kenneth J.·2010·Journal of Thoracic Oncology
DOI 10.1097/jto.0b013e3181f387e4
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/jto.0b013e3181f387e4

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 119

  1. O'Byrne, 2001, Chronic immune activation and inflammation as the cause of malignancy, Br J Cancer, 85, 473, 10.1054/bjoc.2001.1943 · DOI
  2. Evans, 1972, Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity, Immunology, 23, 615
  3. Underwood, 1974, Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review, Br J Cancer, 30, 538, 10.1038/bjc.1974.233 · DOI · Paper page
  4. Mosmann, 1986, Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins, J Immunol, 136, 2348, 10.4049/jimmunol.136.7.2348 · DOI
  5. Finn, 2008, Cancer immunology, N Engl J Med, 358, 2704, 10.1056/NEJMra072739 · DOI · Paper page
  6. Becker, 2006, Molecular immunological approaches to biotherapy of human cancers—a review, hypothesis and implications, Anticancer Res, 26, 1113
  7. Knutson, 2005, Tumor antigen-specific T helper cells in cancer immunity and immunotherapy, Cancer Immunol Immunother, 54, 721, 10.1007/s00262-004-0653-2 · DOI
  8. Terabe, 2004, Role of IL-13 in regulation of anti-tumor immunity and tumor growth, Cancer Immunol Immunother, 53, 79, 10.1007/s00262-003-0445-0 · DOI
  9. O'Byrne, 2000, The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease, Eur J Cancer, 36, 151, 10.1016/S0959-8049(99)00241-5 · DOI
  10. Dalgleish, 2006, Inflammation and cancer: the role of the immune response and angiogenesis, Cancer Treat Res, 130, 1, 10.1007/0-387-26283-0_1 · DOI
  11. Bracke, 2006, Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice, J Immunol, 177, 4350, 10.4049/jimmunol.177.7.4350 · DOI
  12. Cardenas, 1997, Environmental tobacco smoke and lung cancer mortality in the American Cancer Society's Cancer Prevention Study. II, Cancer Causes Control, 8, 57, 10.1023/A:1018483121625 · DOI
  13. Skillrud, 1986, Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study, Ann Intern Med, 105, 503, 10.7326/0003-4819-105-4-503 · DOI
  14. Nomura, 1991, Prospective study of pulmonary function and lung cancer, Am Rev Respir Dis, 144, 307, 10.1164/ajrccm/144.2.307 · DOI
  15. Saetta, 2001, Cellular and structural bases of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 163, 1304, 10.1164/ajrccm.163.6.2009116 · DOI
  16. Vestbo, 2007, Systemic inflammation and progression of COPD, Thorax, 62, 469, 10.1136/thx.2007.077792 · DOI
  17. Mannino, 2003, Low lung function and incident lung cancer in the United States: data from the First National Health and Nutrition Examination Survey follow-up, Arch Intern Med, 163, 1475, 10.1001/archinte.163.12.1475 · DOI
  18. Loganathan, 2006, Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer, Chest, 129, 1305, 10.1378/chest.129.5.1305 · DOI
  19. Alberg, 2007, Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition), Chest, 132, 29S, 10.1378/chest.07-1347 · DOI
  20. Brenner, 2001, Previous pulmonary diseases and risk of lung cancer in Gansu Province, China, Int J Epidemiol, 30, 118, 10.1093/ije/30.1.118 · DOI
  21. Zheng, 1987, Lung cancer and prior tuberculosis infection in Shanghai, Br J Cancer, 56, 501, 10.1038/bjc.1987.233 · DOI
  22. Littman, 2005, Chlamydia pneumoniae and lung cancer: epidemiologic evidence, Cancer Epidemiol Biomarkers Prev, 14, 773, 10.1158/1055-9965.EPI-04-0599 · DOI
  23. Geng, 2000, Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10, J Immunol, 164, 5522, 10.4049/jimmunol.164.10.5522 · DOI
  24. Arenberg, 1996, Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice, J Clin Invest, 97, 2792, 10.1172/JCI118734 · DOI
  25. Haddad, 1968, Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer, Am J Med, 45, 211, 10.1016/0002-9343(68)90039-9 · DOI
  26. Doll, 1955, Mortality from lung cancer in asbestos workers, Br J Ind Med, 12, 81
  27. Smith, 1995, Meta-analysis of studies of lung cancer among silicotics, Epidemiology, 6, 617, 10.1097/00001648-199511000-00010 · DOI
  28. Knox, 1968, Mortality from lung cancer and other causes among workers in an asbestos textile factory, Br J Ind Med, 25, 293
  29. Cassidy, 2007, Occupational exposure to crystalline silica and risk of lung cancer: a multicenter case-control study in Europe, Epidemiology, 18, 36, 10.1097/01.ede.0000248515.28903.3c · DOI
  30. Hubbard, 2000, Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study, Am J Respir Crit Care Med, 161, 5, 10.1164/ajrccm.161.1.9906062 · DOI
  31. Saffiotti, 1996, Alveolar type II cells at the crossroad of inflammation, fibrogenesis, and neoplasia, Am J Pathol, 149, 1423
  32. Masferrer, 2000, Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors, Cancer Res, 60, 1306
  33. Richardson, 2003, Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy, Lung Cancer, 39, 1, 10.1016/S0169-5002(02)00382-3 · DOI
  34. Cuzick, 2009, Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement, Lancet Oncol, 10, 501, 10.1016/S1470-2045(09)70035-X · DOI
  35. Wall, 2007, Nonsteroidal anti-inflammatory drugs and lung cancer risk: a population-based case control study, J Thorac Oncol, 2, 109, 10.1097/JTO.0b013e31802f1cc5 · DOI
  36. Hida, 1998, Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas, Cancer Res, 58, 3761
  37. Hosomi, 2000, Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung, Lung Cancer, 30, 73, 10.1016/S0169-5002(00)00132-X · DOI
  38. Wolff, 1998, Expression of cyclooxygenase-2 in human lung carcinoma, Cancer Res, 58, 4997
  39. Lu, 2004, Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers, J Clin Oncol, 22, 4575, 10.1200/JCO.2004.01.091 · DOI
  40. Kelly, 2008, Biological agents in non-small cell lung cancer: a review of recent advances and clinical results with a focus on epidermal growth factor receptor and vascular endothelial growth factor, J Thorac Oncol, 3, 664, 10.1097/JTO.0b013e3181758141 · DOI
  41. Inamura, 2008, EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers, J Thorac Oncol, 3, 13, 10.1097/JTO.0b013e31815e8b60 · DOI
  42. Whiteside, 2006, Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention, Semin Cancer Biol, 16, 3, 10.1016/j.semcancer.2005.07.008 · DOI
  43. Lipford, 1984, Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung, Am J Surg Pathol, 8, 357, 10.1097/00000478-198405000-00004 · DOI
  44. Lee, 1989, Morphometric and morphologic evaluations in stage III non-small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells, Cancer, 63, 309, 10.1002/1097-0142(19890115)63:2<309::AID-CNCR2820630218>3.0.CO;2-N · DOI
  45. Welsh, 2005, Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer, J Clin Oncol, 23, 8959, 10.1200/JCO.2005.01.4910 · DOI
  46. Galon, 2006, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome, Science, 313, 1960, 10.1126/science.1129139 · DOI · Paper page
  47. Piersma, 2007, High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer, Cancer Res, 67, 354, 10.1158/0008-5472.CAN-06-3388 · DOI · Paper page
  48. Kondratiev, 2004, Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma, Clin Cancer Res, 10, 4450, 10.1158/1078-0432.CCR-0732-3 · DOI
  49. Oudejans, 2002, High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent, J Pathol, 198, 468, 10.1002/path.1236 · DOI
  50. Grabenbauer, 2006, Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma, Clin Cancer Res, 12, 3355, 10.1158/1078-0432.CCR-05-2434 · DOI
  51. Oudejans, 1997, Activated cytotoxic T cells as prognostic marker in Hodgkin's disease, Blood, 89, 1376, 10.1182/blood.V89.4.1376 · DOI
  52. Rodriguez, 2004, Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses, Cancer Res, 64, 5839, 10.1158/0008-5472.CAN-04-0465 · DOI · Paper page
  53. Whiteside, 2003, Immune responses to malignancies, J Allergy Clin Immunol, 111, S677, 10.1067/mai.2003.90 · DOI
  54. Sogn, 1998, Tumor immunology: the glass is half full, Immunity, 9, 757, 10.1016/S1074-7613(00)80641-X · DOI
  55. Chen, 2005, Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo, Proc Natl Acad Sci USA, 102, 419, 10.1073/pnas.0408197102 · DOI · Paper page
  56. Ortegel, 2000, Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small-cell lung carcinoma, Cancer Immunol Immunother, 48, 627, 10.1007/s002620050011 · DOI
  57. Tormanen-Napankangas, 2001, High number of tumour-infiltrating lymphocytes is associated with apoptosis in non-small cell lung carcinoma, APMIS, 109, 525, 10.1111/j.1600-0463.2001.apm090706.x · DOI
  58. Riemann, 1997, Phenotypic analysis of T lymphocytes isolated from non-small-cell lung cancer, Int Arch Allergy Immunol, 114, 38, 10.1159/000237640 · DOI
  59. Johnson, 2000, Immune cell infiltrates and prognosis in primary carcinoma of the lung, Lung Cancer, 27, 27, 10.1016/S0169-5002(99)00095-1 · DOI
  60. Trojan, 2004, Immune activation status of CD8+ T cells infiltrating non-small cell lung cancer, Lung Cancer, 44, 143, 10.1016/j.lungcan.2003.11.004 · DOI
  61. Kawai, 2008, Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer, Cancer, 113, 1387, 10.1002/cncr.23712 · DOI
  62. Al-Shibli, 2008, Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer, Clin Cancer Res, 14, 5220, 10.1158/1078-0432.CCR-08-0133 · DOI
  63. Hiraoka, 2006, Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma, Br J Cancer, 94, 275, 10.1038/sj.bjc.6602934 · DOI
  64. Wakabayashi, 2003, CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers, Cancer Sci, 94, 1003, 10.1111/j.1349-7006.2003.tb01392.x · DOI
  65. Weynants, 1988, Cytolytic response of human T cells against allogeneic small cell lung carcinoma treated with interferon gamma, Cancer Immunol Immunother, 27, 228, 10.1007/BF00205444 · DOI
  66. Huang, 1995, Human non-small cell lung cancer cells express a type 2 cytokine pattern, Cancer Res, 55, 3847
  67. De Vita, 2000, Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients, Chest, 117, 365, 10.1378/chest.117.2.365 · DOI
  68. Urosevic, 2001, Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production, Am J Pathol, 159, 817, 10.1016/S0002-9440(10)61756-7 · DOI
  69. Woo, 2001, Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer, Cancer Res, 61, 4766
  70. Foukas, 2001, Expression of HLA-DR is reduced in tumor infiltrating immune cells (TIICs) and regional lymph nodes of non-small-cell lung carcinomas. A putative mechanism of tumor-induced immunosuppression?, Anticancer Res, 21, 2609
  71. Kataki, 2002, Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression, J Lab Clin Med, 140, 320, 10.1067/mlc.2002.128317 · DOI
  72. Ortegel, 2002, Modulation of tumor-infiltrating lymphocyte cytolytic activity against human non-small cell lung cancer, Lung Cancer, 36, 17, 10.1016/S0169-5002(01)00472-X · DOI
  73. Fontenot, 2005, A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3, Nat Immunol, 6, 331, 10.1038/ni1179 · DOI
  74. Willimsky, 2005, Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance, Nature, 437, 141, 10.1038/nature03954 · DOI
  75. Woo, 2002, Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation, J Immunol, 168, 4272, 10.4049/jimmunol.168.9.4272 · DOI
  76. Thornton, 1998, CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production, J Exp Med, 188, 287, 10.1084/jem.188.2.287 · DOI
  77. Sharma, 2005, Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer, Cancer Res, 65, 5211, 10.1158/0008-5472.CAN-05-0141 · DOI
  78. Petersen, 2006, Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients, Cancer, 107, 2866, 10.1002/cncr.22282 · DOI
  79. Young, 1986, Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity, Cell, 44, 849, 10.1016/0092-8674(86)90007-3 · DOI
  80. Phillips, 1985, Effect of smoking on human natural killer cell activity, Cancer, 56, 2789, 10.1002/1097-0142(19851215)56:12<2789::AID-CNCR2820561213>3.0.CO;2-2 · DOI
  81. Takeuchi, 1988, Effect of smoking on natural killer cell activity in the lung, Chest, 94, 688, 10.1378/chest.94.4.688 · DOI
  82. Esendagli, 2008, Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer, Lung Cancer, 59, 32, 10.1016/j.lungcan.2007.07.022 · DOI
  83. Wahl, 2006, The kiss of death: interrupted by NK-cell close encounters of another kind, Trends Immunol, 27, 161, 10.1016/j.it.2006.02.002 · DOI
  84. Kerr, 1998, Partial regression in primary carcinoma of the lung: does it occur?, Histopathology, 33, 55, 10.1046/j.1365-2559.1998.00453.x · DOI
  85. Takanami, 2001, The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma, J Thorac Cardiovasc Surg, 121, 1058, 10.1067/mtc.2001.113026 · DOI
  86. Villegas, 2002, Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer, Lung Cancer, 35, 23, 10.1016/S0169-5002(01)00292-6 · DOI
  87. Katou, 2007, Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer, Cancer Res, 67, 11195, 10.1158/0008-5472.CAN-07-2637 · DOI
  88. Siziopikou, 1997, Augmentation of impaired tumoricidal function in alveolar macrophages from lung cancer patients by cocultivation with allogeneic, but not autologous lymphocytes, Cancer Immunol Immunother, 45, 29, 10.1007/s002620050397 · DOI
  89. Carrega, 2008, Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells, Cancer, 112, 863, 10.1002/cncr.23239 · DOI
  90. Brittenden, 1996, Natural killer cells and cancer, Cancer, 77, 1226, 10.1002/(SICI)1097-0142(19960401)77:7<1226::AID-CNCR2>3.0.CO;2-G · DOI
  91. Bingle, 2002, The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies, J Pathol, 196, 254, 10.1002/path.1027 · DOI · Paper page
  92. Dimitriadou, 1997, Mast cell-tumor cell interactions: for or against tumour growth and metastasis?, Anticancer Res, 17, 1541
  93. Chen, 2003, Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer, Clin Cancer Res, 9, 729
  94. Toomey, 2003, Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: no association with prognosis identified in 3-year follow-up, Int J Cancer, 103, 408, 10.1002/ijc.10836 · DOI
  95. Lewis, 2006, Distinct role of macrophages in different tumor microenvironments, Cancer Res, 66, 605, 10.1158/0008-5472.CAN-05-4005 · DOI · Paper page
  96. Ohri, 2009, Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival, Eur Respir J, 33, 118, 10.1183/09031936.00065708 · DOI
  97. Kim, 2008, High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer, Br J Cancer, 98, 1118, 10.1038/sj.bjc.6604256 · DOI
  98. Takanami, 1999, Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis, Oncology, 57, 138, 10.1159/000012021 · DOI
  99. Zeni, 2007, Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer, Eur Respir J, 30, 627, 10.1183/09031936.00129306 · DOI
  100. Bunt, 2006, Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression, J Immunol, 176, 284, 10.4049/jimmunol.176.1.284 · DOI
  101. Song, 2005, CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells, J Immunol, 175, 8200, 10.4049/jimmunol.175.12.8200 · DOI
  102. Nagaraj, 2007, Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer, Nat Med, 13, 828, 10.1038/nm1609 · DOI
  103. Almand, 2001, Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer, J Immunol, 166, 678, 10.4049/jimmunol.166.1.678 · DOI
  104. Marigo, 2008, Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells, Immunol Rev, 222, 162, 10.1111/j.1600-065X.2008.00602.x · DOI · Paper page
  105. Huang, 2006, Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host, Cancer Res, 66, 1123, 10.1158/0008-5472.CAN-05-1299 · DOI · Paper page
  106. Dean, 1993, Mast cells in the synovium and synovial fluid in osteoarthritis, Br J Rheumatol, 32, 671, 10.1093/rheumatology/32.8.671 · DOI
  107. Trautmann, 2000, Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo, J Pathol, 190, 100, 10.1002/(SICI)1096-9896(200001)190:1<100::AID-PATH496>3.0.CO;2-Q · DOI
  108. Aaltomaa, 1993, Mast cells in breast cancer, Anticancer Res, 13, 785
  109. Elpek, 2001, The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus, J Clin Pathol, 54, 940, 10.1136/jcp.54.12.940 · DOI
  110. Lachter, 1995, Mast cells in colorectal neoplasias and premalignant disorders, Dis Colon Rectum, 38, 290, 10.1007/BF02055605 · DOI
  111. Meininger, 1992, Mast cells and angiogenesis, Semin Cancer Biol, 3, 73
  112. Blair, 1997, Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor, J Clin Invest, 99, 2691, 10.1172/JCI119458 · DOI
  113. Ibaraki, 2005, The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer, Eur J Cardiothorac Surg, 28, 617, 10.1016/j.ejcts.2005.06.020 · DOI
  114. Imada, 2000, Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma, Eur Respir J, 15, 1087, 10.1034/j.1399-3003.2000.01517.x · DOI
  115. Takanami, 2000, Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma, Cancer, 88, 2686, 10.1002/1097-0142(20000615)88:12<2686::AID-CNCR6>3.0.CO;2-6 · DOI
  116. Tomita, 2000, Effect of mast cells on tumor angiogenesis in lung cancer, Ann Thorac Surg, 69, 1686, 10.1016/S0003-4975(00)01160-7 · DOI
  117. Tomita, 1999, Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma, Lung Cancer, 26, 103, 10.1016/S0169-5002(99)00076-8 · DOI
  118. Tataroglu, 2004, Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC), Lung Cancer, 43, 47, 10.1016/j.lungcan.2003.08.013 · DOI
  119. Smith, 2006, Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers, Inhal Toxicol, 18, 667, 10.1080/08958370600742821 · DOI

Cited by

Metadata

Authors
O'Callaghan, D. S., O'Donnell, D., O'Connell, F., & O'Byrne, K. J.
Venue
Journal of Thoracic Oncology
Publisher
Elsevier BV
Published
2010-12
Volume
5
Issue
12
Pages
2024-2036
ISSN
1556-0864
DOI
10.1097/jto.0b013e3181f387e4
Cited by
241
References
6
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.